Arelis Madera MD in North Fort Myers, Florida

Home Florida North Fort Myers

Arelis Madera MD has Endocrinology as her primary medical specialty. Their primary office is: 3434 Hancock Bridge Pkwy in North Fort Myers, Florida. There are 18 additional office locations for Arelis Madera MD that can be viewed towards the end of their profile.

They're a part of the: Millennium Physician Group Llc medical group which has around 793 members. You can call their office at 877-856-3774 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1986 (around 38 years of experience). They are listed as doing telehealth appointments.

Arelis M Madera MD Office Phone and Directions

Arelis Madera MD
Millennium Physician Group Llc
3434 Hancock Bridge Pkwy
North Fort Myers, Florida 33903
877-856-3774

Patient Ratings
Please rate your experience with Arelis Madera MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 877-856-3774

Enter a starting address:

Healthcare Info for Arelis Madera MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1986
The Primary Medical Specialty for Arelis Madera MD is listed as: Endocrinology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 5991608291
NPI #: 1487697272
NPI Created On: 06/13/2006
NPI Last Updated Listed as: 10/02/2014
Primary Taxonomy Code: 207RE0101X
License Number:
ME74893
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood test, comprehensive group of blood chemicals
Blood test, lipids (cholesterol and triglycerides)
Urine microalbumin (protein) level
Vitamin d-3 level
Cortisol (hormone) measurement
Creatinine level to test for kidney function or muscle injury
Cyanocobalamin (vitamin b-12) level
Blood glucose (sugar) test performed by hand-held instrument
Hemoglobin a1c level
Thyroxine (thyroid chemical) measurement
Blood test, thyroid stimulating hormone (tsh)
C-peptide (protein) level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Continuous monitoring of glucose in tissue fluid using sensor under skin
Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours
Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792511067

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Endocrinology

Name of Drug #1: Tirosint

Open Associated Drug #1: 71858-0010-4

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792511069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Endocrinology

Name of Drug #1: Tirosint

Open Associated Drug #1: 71858-0010-4

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813514155

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433385

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433409

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $105

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433391

Being Disputed:: No

Product Related: No

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: Millennium Physician Group

Third party is a Charity:: No

Record ID:: 795433403

Being Disputed:: No

Product Related: No

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795433415

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Additional Office Locations

1. Millennium Physician Group Llc
3571 Del Prado Blvd N
Cape Coral, FL 33909
Suite 2
Group Members: 793